Mandate

Vinge acts for SUSI Partners on its acquisition of the Lyngsåsa wind park

September 09, 2019 M&A Energy

Vinge has acted for SUSI Partners, manager of the SUSI Renewable Energy Fund II, in connection with its acquisition of the Lyngsåsa wind park in Alvesta municipality.

As part of the transaction, SUSI Partners has secured a long-term fixed price Power Purchase Agreement (PPA) and arranged for debt financing with Hamburg Commercial Bank for the project.

The Lyngsåsa wind park will consist of 22 Vestas V150 turbines with a total capacity of 94.6 MW. The project has been developed from greenfield by BayWa r.e., with operations scheduled to begin in 2021. BayWa will also manage the complete engineering, procurement and construction (EPC) of the turnkey project. Annual production will be around 315GWh, providing electricity to the equivalent of 80,000 households, while saving approximately 93,000 tons of CO2 emissions each year.

Vinge’s team was headed by M&A partner Peter Sundgren and included e.g. partners Christoffer Thalin (M&A), Johan Cederblad (permits), Thomas Sjöberg (permits), Assur Badur (real estate), Matthias Pannier (M&A), Robert Deli (real estate); counsel Sofia Törnroth Nyberg (project financing), Maria Schultzberg (tax), Fredrik Christiansson (project financing); and associates Jack Bengtsson (project financing), Axel Jansson (project financing), Hampus Olsson (real estate), Karolina Cohrs (real estate), Vilhelm Rondahl (M&A) and Rasmus Perdahl (M&A).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025